Cargando…

Albumin redox state of maintenance haemodialysis patients is positively altered after treatment

BACKGROUND AND AIM: Maintenance haemodialysis patients have increased morbidity and mortality which is mainly driven by an elevated inflammation level due to the uraemic milieu. A major part of this increased inflammation level is the degree of oxidative stress which can be assessed by albumin redox...

Descripción completa

Detalles Bibliográficos
Autores principales: Boss, Kristina, Paar, Margret, Waterstradt, Katja, Schnurr, Kerstin, Ickerott, Philipp, Wieneke, Ulrike, Spitthöver, Ralf, Oettl, Karl, Kribben, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10506191/
https://www.ncbi.nlm.nih.gov/pubmed/37723426
http://dx.doi.org/10.1186/s12882-023-03317-9
_version_ 1785107067902623744
author Boss, Kristina
Paar, Margret
Waterstradt, Katja
Schnurr, Kerstin
Ickerott, Philipp
Wieneke, Ulrike
Spitthöver, Ralf
Oettl, Karl
Kribben, Andreas
author_facet Boss, Kristina
Paar, Margret
Waterstradt, Katja
Schnurr, Kerstin
Ickerott, Philipp
Wieneke, Ulrike
Spitthöver, Ralf
Oettl, Karl
Kribben, Andreas
author_sort Boss, Kristina
collection PubMed
description BACKGROUND AND AIM: Maintenance haemodialysis patients have increased morbidity and mortality which is mainly driven by an elevated inflammation level due to the uraemic milieu. A major part of this increased inflammation level is the degree of oxidative stress which can be assessed by albumin redox state (ARS). Aim of this study was to evaluate how the ARS is affected by a haemodialysis treatment and different dialyzer properties. METHODS: ARS was determined before and after haemodialysis treatment by fractionating it into reduced human mercaptalbumin (HMA), reversibly oxidized human non-mercaptalbumin 1 (HNA-1), and irreversibly oxidized human non-mercaptalbumin 2 (HNA-2) by high-performance liquid chromatography. In healthy individuals, albumin circulates in the following proportions: HMA 70–80%, HNA-1 20–30% and HNA-2 2–5%. High flux (FX 100 [Fresenius Medical Care], BG 1.8 [Toray], Xevonta Hi 18 [B. Braun], CTA-2000 [Kawasumi]) and low flux FX10 [Fresenius Medical Care] dialyzers were used. RESULTS: 58 patients (59% male, median age 68 years, median time on haemodialysis 32 month) were included in the study. Before haemodialysis treatment, HMA (median 55.9%, IQR 50.1–61.2%) was substantially lower than in healthy individuals. Accordingly, oxidized albumin fractions were above the level of healthy individuals (median HNA-1 38.5%, IQR 33.3–43.2%; median HNA-2 5.8%, IQR 5.1–6.7%). Before haemodialysis treatment HMA was significantly higher in patients usually treated with high flux membranes (p < 0.01). After haemodialysis treatment there was a significant increase of HMA and a decrease of HNA-1 and HNA-2 (p < 0.01). These effects were more pronounced in patients treated with high flux dialyzers (p < 0.01). There were no differences of ARS alteration with regard to the dialyzer´s sterilization mode or the presence of diabetes. CONCLUSION: The study confirms that the ARS is positively altered by haemodialysis and shows for the first time that this effect depends on dialyzer properties. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12882-023-03317-9.
format Online
Article
Text
id pubmed-10506191
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-105061912023-09-19 Albumin redox state of maintenance haemodialysis patients is positively altered after treatment Boss, Kristina Paar, Margret Waterstradt, Katja Schnurr, Kerstin Ickerott, Philipp Wieneke, Ulrike Spitthöver, Ralf Oettl, Karl Kribben, Andreas BMC Nephrol Research BACKGROUND AND AIM: Maintenance haemodialysis patients have increased morbidity and mortality which is mainly driven by an elevated inflammation level due to the uraemic milieu. A major part of this increased inflammation level is the degree of oxidative stress which can be assessed by albumin redox state (ARS). Aim of this study was to evaluate how the ARS is affected by a haemodialysis treatment and different dialyzer properties. METHODS: ARS was determined before and after haemodialysis treatment by fractionating it into reduced human mercaptalbumin (HMA), reversibly oxidized human non-mercaptalbumin 1 (HNA-1), and irreversibly oxidized human non-mercaptalbumin 2 (HNA-2) by high-performance liquid chromatography. In healthy individuals, albumin circulates in the following proportions: HMA 70–80%, HNA-1 20–30% and HNA-2 2–5%. High flux (FX 100 [Fresenius Medical Care], BG 1.8 [Toray], Xevonta Hi 18 [B. Braun], CTA-2000 [Kawasumi]) and low flux FX10 [Fresenius Medical Care] dialyzers were used. RESULTS: 58 patients (59% male, median age 68 years, median time on haemodialysis 32 month) were included in the study. Before haemodialysis treatment, HMA (median 55.9%, IQR 50.1–61.2%) was substantially lower than in healthy individuals. Accordingly, oxidized albumin fractions were above the level of healthy individuals (median HNA-1 38.5%, IQR 33.3–43.2%; median HNA-2 5.8%, IQR 5.1–6.7%). Before haemodialysis treatment HMA was significantly higher in patients usually treated with high flux membranes (p < 0.01). After haemodialysis treatment there was a significant increase of HMA and a decrease of HNA-1 and HNA-2 (p < 0.01). These effects were more pronounced in patients treated with high flux dialyzers (p < 0.01). There were no differences of ARS alteration with regard to the dialyzer´s sterilization mode or the presence of diabetes. CONCLUSION: The study confirms that the ARS is positively altered by haemodialysis and shows for the first time that this effect depends on dialyzer properties. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12882-023-03317-9. BioMed Central 2023-09-18 /pmc/articles/PMC10506191/ /pubmed/37723426 http://dx.doi.org/10.1186/s12882-023-03317-9 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Boss, Kristina
Paar, Margret
Waterstradt, Katja
Schnurr, Kerstin
Ickerott, Philipp
Wieneke, Ulrike
Spitthöver, Ralf
Oettl, Karl
Kribben, Andreas
Albumin redox state of maintenance haemodialysis patients is positively altered after treatment
title Albumin redox state of maintenance haemodialysis patients is positively altered after treatment
title_full Albumin redox state of maintenance haemodialysis patients is positively altered after treatment
title_fullStr Albumin redox state of maintenance haemodialysis patients is positively altered after treatment
title_full_unstemmed Albumin redox state of maintenance haemodialysis patients is positively altered after treatment
title_short Albumin redox state of maintenance haemodialysis patients is positively altered after treatment
title_sort albumin redox state of maintenance haemodialysis patients is positively altered after treatment
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10506191/
https://www.ncbi.nlm.nih.gov/pubmed/37723426
http://dx.doi.org/10.1186/s12882-023-03317-9
work_keys_str_mv AT bosskristina albuminredoxstateofmaintenancehaemodialysispatientsispositivelyalteredaftertreatment
AT paarmargret albuminredoxstateofmaintenancehaemodialysispatientsispositivelyalteredaftertreatment
AT waterstradtkatja albuminredoxstateofmaintenancehaemodialysispatientsispositivelyalteredaftertreatment
AT schnurrkerstin albuminredoxstateofmaintenancehaemodialysispatientsispositivelyalteredaftertreatment
AT ickerottphilipp albuminredoxstateofmaintenancehaemodialysispatientsispositivelyalteredaftertreatment
AT wienekeulrike albuminredoxstateofmaintenancehaemodialysispatientsispositivelyalteredaftertreatment
AT spitthoverralf albuminredoxstateofmaintenancehaemodialysispatientsispositivelyalteredaftertreatment
AT oettlkarl albuminredoxstateofmaintenancehaemodialysispatientsispositivelyalteredaftertreatment
AT kribbenandreas albuminredoxstateofmaintenancehaemodialysispatientsispositivelyalteredaftertreatment